Carregant...
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/124013
Management Of Tizanidine Withdrawal Syndrome: A Case Report
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Most drugs that act on the central nervous system (CNS) require dose titration to avoid withdrawal syndrome. Tizanidine withdrawal syndrome is caused by adrenergic discharge due to its alpha(2)-agonist mechanism and is characterized by hypertension, reflex tachycardia, hypertonicity, and anxiety. Although tizanidine withdrawal syndrome is mentioned as a potential side effect of cessation, it is not common and there have been few reports. We present the case of a 31-year-old woman with tizanidine withdrawal syndrome after discontinuing medication prescribed for a muscle contracture (tizanidine). She showed high adrenergic activity with nausea, vomiting, generalized tremor, dysthermia, hypertension, and tachycardia. Symptoms were reversed and successful reweaning was achieved by restarting tizanidine followed by slow downward titration. Withdrawal syndrome should be considered when drugs targeting the CNS are suddenly stopped. Weaning regimens should be closely monitored for acute withdrawal reactions.
Matèries
Matèries (anglès)
Citació
Citació
SUAREZ LLEDÓ, A., PADULLÉS ZAMORA, Ariadna, LOZANO, T., COBO SACRISTÁN, Sara, COLLS GONZÁLEZ, Montserrat, JÓDAR MASANÉS, Ramón josé. Management Of Tizanidine Withdrawal Syndrome: A Case Report. _Clinical Medicine Insights: Case Reports_. 2018. Vol. 11. [consulta: 7 de febrer de 2026]. [Disponible a: https://hdl.handle.net/2445/124013]